Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-4348.25US
AY.39.1.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.39.1.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.15 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.15 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.15 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.15 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.75.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-16208.9France
BA.2.75.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BA.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-11746.4China
BA.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.134ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.134NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.39.1.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.39.1.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.3 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BN.1.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BA.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Q.2 (Alpha)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Q.2 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.2 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used